Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial - Discussion.

4 May 2019 (09:16 - 09:18)

Organised by:

10 More presentations in this session

Presentation thumbnail

This session is part of the Level 1 certification in CMR.

Presentation thumbnail

Myocardial Fibrosis and Prognosis in Heart Transplant Recipients

Professor C. Shenoy (Minneapolis, US)

Presentation thumbnail

Myocardial Fibrosis and Prognosis in Heart Transplant Recipients - Discussion.

Presentation thumbnail

Baseline Results from the NHLBI Hypertrophic Cardiomyopathy Registry

Professor S. Neubauer (Oxford, GB)

Presentation thumbnail

Baseline Results from the NHLBI Hypertrophic Cardiomyopathy Registry - Discussion.

Access the full session

Session thumbnail

Late-Breaking Science session: the best looks from the Venice Film Festival: trials and population studies

The Event

EuroCMR 2019

4 May 2019 09:16 CET

You may be interested in

Congress Presentation

Intracoronary thrombolysis facilitated primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials

27 August 2022

Congress Presentation

Microvascular perfusion patterns identified by contrast-enhanced CMR: prognostic implications in STEMI

31 August 2025

Congress Presentation

Clinical factors associated with microvascular obstruction in early presenters of ST-segment elevation myocardial infarction

28 August 2020

Congress Presentation

Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention

27 August 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources